Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Hakluyt records another year of strong growth driven by value of human insights, expertise and experience

prnewswire.com
UBER AAPL

Chemotherapy Market to Hit $20.99 Billion by 2035, Driven by Rising Cancer Incidence – SNS Insider

globenewswire.com
NVS PFE

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

globenewswire.com
ICU

YY Group Holding (NASDAQ: YYGH) Pauses At-The-Market Offering

globenewswire.com
YYGH

Eva Live Inc. Engages Anderson Kill P.C. to Execute Nasdaq Tokenization Strategy for GOAI

globenewswire.com
GOAI

CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial

globenewswire.com
CERO

Turbo Energy Expects to Report 130%–140% Revenue Growth, Reaching $22.5 – $23.5 Million in 2025 Based on Preliminary Unaudited Results

globenewswire.com
TURB

Eva Live Inc. Engages Anderson Kill P.C. to Execute Nasdaq Tokenization Strategy for GOAI

globenewswire.com
GOAI

Stratasys Selected for Multi-million Dollar U.S. Department of War Additive Manufacturing Program

businesswire.com
SSYS

CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial

globenewswire.com
CERO
View all news →